SCHEMBL6887353

SCHEMBL6887353

COc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@H](O)[C@H]1O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC29A1 Q99808 4/20 0.70
ADORA1 P30542 2/20 0.69
ADORA2A P29274 2/20 0.69
ADORA2B P29275 2/20 0.69
DPP4 P27487 1/20 0.69
MEN1 O00255 1/20 0.69
SLC28A1 O00337 1/20 0.69
MAP3K7 O43318 1/20 0.69
SLC28A2 O43868 1/20 0.69
GAPDH P04406 1/20 0.69
ADORA3 P0DMS8 1/20 0.69
MAPK1 P28482 1/20 0.69
STAT6 P42226 1/20 0.69
PI4KA P42356 1/20 0.69
KMT2A Q03164 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
PI4K2B Q8TCG2 1/20 0.69
DOT1L Q8TEK3 1/20 0.69
PI4K2A Q9BTU6 1/20 0.69
SLC28A3 Q9HAS3 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4081006 1.00 SLC29A1 (0.70) SLC29A1ADORA1ADORA2AADORA2BDPP4
SCHEMBL6903709 1.00 SLC29A1 (0.70) SLC29A1ADORA1ADORA2AADORA2BDPP4
SCHEMBL1979130 1.00 SLC29A1 (0.70) SLC29A1ADORA1ADORA2AADORA2BDPP4
SCHEMBL9142042 1.00 SLC29A1 (0.70) SLC29A1ADORA1ADORA2AADORA2BDPP4
SCHEMBL2589566 0.90 SLC29A1 (0.58) SLC29A1ADORA1ADORA2AADORA2BDPP4
SCHEMBL8970336 0.90 SLC29A1 (0.58) SLC29A1ADORA1ADORA2AADORA2BDPP4
SCHEMBL12552334 0.90 SLC29A1 (0.58) SLC29A1ADORA1ADORA2AADORA2BDPP4
SCHEMBL8970347 0.90 SLC29A1 (0.58) SLC29A1ADORA1ADORA2AADORA2BDPP4
SCHEMBL9141461 0.89 SLC29A1 (0.72) SLC29A1ADORA1ADORA2AADORA2BDPP4
SCHEMBL13265481 0.88 SLC29A1 (0.67) SLC29A1ADORA1ADORA2AADORA2BDPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1411954-A2 MODIFIED NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS AND ABNORMAL CELLULAR PROLIFERATION Pharmasset Limited (BB) 2004-04-28 EP disclosed
WO-2002032920-A2 MODIFIED NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS AND ABNORMAL CELLULAR PROLIFERATION PHARMASSET LIMITED (BB) 2002-04-25 WO disclosed